OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73 | -17.0% | 19,110 | -28.7% | 0.00% | – |
| Q2 2023 | $88 | -91.2% | 26,800 | +6989.9% | 0.00% | – |
| Q2 2021 | $1,000 | -99.4% | 378 | -99.0% | 0.00% | – |
| Q1 2021 | $157,000 | +74.4% | 39,000 | 0.0% | 0.00% | – |
| Q4 2020 | $90,000 | -60.0% | 39,000 | -0.5% | 0.00% | – |
| Q3 2020 | $225,000 | -22.1% | 39,200 | 0.0% | 0.00% | – |
| Q2 2020 | $289,000 | +1964.3% | 39,200 | +396.2% | 0.00% | – |
| Q1 2019 | $14,000 | -26.3% | 7,900 | 0.0% | 0.00% | – |
| Q4 2018 | $19,000 | -57.8% | 7,900 | 0.0% | 0.00% | – |
| Q3 2018 | $45,000 | -27.4% | 7,900 | 0.0% | 0.00% | – |
| Q2 2018 | $62,000 | +10.7% | 7,900 | 0.0% | 0.00% | – |
| Q1 2018 | $56,000 | -28.2% | 7,900 | 0.0% | 0.00% | – |
| Q4 2017 | $78,000 | +14.7% | 7,900 | 0.0% | 0.00% | – |
| Q3 2017 | $68,000 | -18.1% | 7,900 | 0.0% | 0.00% | – |
| Q2 2017 | $83,000 | – | 7,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $5,068 | 20.50% |
| Madison Avenue Partners, LP | 3,648,509 | $14,010,275 | 1.99% |
| CHI Advisors LLC | 864,822 | $3,320,916 | 1.32% |
| EcoR1 Capital, LLC | 6,117,400 | $23,490,816 | 0.79% |
| Rubric Capital Management LP | 5,445,910 | $20,912,294 | 0.78% |
| BVF INC/IL | 6,851,051 | $26,308,036 | 0.71% |
| Artal Group S.A. | 2,500,000 | $9,600 | 0.41% |
| DCF Advisers, LLC | 30,430 | $116,851 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 458,700 | $1,761,408 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,701,228 | $6,531 | 0.03% |